公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

154 记录

产品持有公司班级有效性
DG Gel ABO/Rh(2D)+Kell80134860210GRIFOLS BRASIL LTDAIV10/08/2035
DG Gel ABO/Rh+Kell (RT)80134860211GRIFOLS BRASIL LTDAIV10/08/2035
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay80134860319GRIFOLS BRASIL LTDAIV28/07/2035
Procleix Parvo/HAV Assay - Calibrators and Control Kit80134860318GRIFOLS BRASIL LTDAIII14/07/2035
Procleix Ultrio Elite Assay Calibrators80134860317GRIFOLS BRASIL LTDAIV07/07/2035
ID CORE CONTROL80134860315GRIFOLS BRASIL LTDAIV30/06/2035
Diego(a)-Cyte 3%80134860316GRIFOLS BRASIL LTDAIII30/06/2035
Sero-Cyte Pool 0,8%80134860209GRIFOLS BRASIL LTDAIII29/06/2035
Família Procleix UltrioPlex E Assay Calibrators80134860314GRIFOLS BRASIL LTDAIV23/06/2035
ANTI-SOROS DE FENÓTIPO EXTENDIDO80134860200GRIFOLS BRASIL LTDAIV27/04/2035
Discriminatory Probe Reagent (Procleix ArboPlex Assay)80134860313GRIFOLS BRASIL LTDAIV22/04/2035
Procleix Parvo/HAV Assay80134860310GRIFOLS BRASIL LTDAIII07/04/2035
Procleix ArboPlex Assay80134860311GRIFOLS BRASIL LTDAIV07/04/2035
Procleix ArboPlex Assay Calibrators80134860312GRIFOLS BRASIL LTDAIV07/04/2035
SERIGRUP DIANA A1/B80134860084GRIFOLS BRASIL LTDAIV28/12/2034
SERASCAN DIANA DIA80134860123GRIFOLS BRASIL LTDAIII28/09/2034
ID RHD XT REAGENTES80134860307GRIFOLS BRASIL LTDAIV18/03/2034
Procleix UltrioPlex E Assay80134860306GRIFOLS BRASIL LTDAIV19/02/2034
Anti-C3d80134860302GRIFOLS BRASIL LTDAIII11/12/2033
Anti-IgG80134860303GRIFOLS BRASIL LTDAIII11/12/2033
DG Gel DC Scan Plus80134860304GRIFOLS BRASIL LTDAIII11/12/2033
Coombs Control80134860301GRIFOLS BRASIL LTDAIII04/12/2033
Screen-Cyte Dia 3%80134860297GRIFOLS BRASIL LTDAIII23/10/2033
Sero-Cyte 3%80134860299GRIFOLS BRASIL LTDAIII23/10/2033
Data-Cyte Plus 3%80134860300GRIFOLS BRASIL LTDAIII23/10/2033

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家